$GUER
Guerrilla RF Inc Stock $guer

$guer Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000143774923005378 Filed on March 03, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$3.231M	$2.428M	$11.60M
YoY Change	-16.43%	-76.83%	10.7%
Cost Of Revenue	$1.403M	$1.060M	$4.836M
YoY Change	-9.3%	-75.58%	11.41%
Gross Profit	$1.828M	$1.369M	$6.765M
YoY Change	-21.18%	-77.71%	10.19%
Gross Profit Margin	56.56%	56.36%	58.32%
Selling, General & Admin	$2.908M	$2.496M	$9.772M
YoY Change	25.05%	-51.74%	87.34%
% of Gross Profit	159.13%	182.38%	144.45%
Research & Development	$2.586M	$2.198M	$8.114M
YoY Change	43.52%	-52.14%	76.67%
% of Gross Profit	141.51%	160.61%	119.94%
Depreciation & Amortization	$398.3K	$456.9K	$1.358M
YoY Change	58.73%	23.02%	265.49%
% of Gross Profit	21.8%	33.39%	20.07%
Operating Expenses	$5.494M	$4.694M	$17.89M
YoY Change	33.11%	-51.93%	82.34%
Operating Profit	-$3.667M	-$3.326M	-$11.12M
YoY Change	102.71%	-8.26%	203.06%
Interest Expense	-$341.9K	-$443.3K	-$874.7K
YoY Change	497.43%	-19.62%	-258.61%
% of Operating Profit
Other Income/Expense, Net	-$334.7K	$17.75K	-$905.2K
YoY Change	484.89%	-98.72%	-165.4%
Pretax Income	-$4.001M	-$3.751M	-$12.03M
YoY Change	114.43%	34.33%	323.9%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$4.000M	-$3.751M	-$12.00M
YoY Change	114.35%	34.33%	328.57%
Net Earnings / Revenue	-123.8%	-154.48%	-103.44%
Basic Earnings Per Share	-$0.62		-$0.36
Diluted Earnings Per Share	-$0.62	-$0.11	-$0.36
COMMON SHARES
Basic Shares Outstanding	40.55M	33.72M	33.30M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.878M	$4.340M	$4.340M
YoY Change	-27.53%	-18.32%	-18.32%
Cash & Equivalents	$1.878M	$4.340M	$4.340M
Short-Term Investments
Other Short-Term Assets	$770.2K	$643.4K	$643.4K
YoY Change	-26.03%	-45.82%	-45.82%
Inventory	$1.584M	$1.673M	$1.673M
Prepaid Expenses	$770.2K	$643.4K
Receivables	$1.596M	$1.125M	$1.125M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.828M	$7.782M	$7.782M
YoY Change	-26.05%	-19.0%	-19.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.984M	$5.098M	$5.308M
YoY Change	20.66%	396.26%	416.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$90.08K	$3.575M	$3.575M
YoY Change
Total Long-Term Assets	$15.97M	$8.883M	$8.883M
YoY Change	262.42%	764.64%	764.63%
TOTAL ASSETS
Total Short-Term Assets	$5.828M	$7.782M	$7.782M
Total Long-Term Assets	$15.97M	$8.883M	$8.883M
Total Assets	$21.80M	$16.66M	$16.66M
YoY Change	77.41%	56.7%	56.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.374M	$4.466M	$4.466M
YoY Change	68.54%	276.42%	276.42%
Accrued Expenses	$568.0K	$139.8K	$139.8K
YoY Change	389.11%
Deferred Revenue
YoY Change
Short-Term Debt	$1.363M	$959.8K	$959.8K
YoY Change			18646.09%
Long-Term Debt Due	$1.092M	$1.079M	$1.079M
YoY Change	63.17%	810.75%	810.75%
Total Short-Term Liabilities	$5.397M	$6.644M	$6.644M
YoY Change	145.18%	407.19%	407.19%
LONG-TERM LIABILITIES
Long-Term Debt	$7.631M	$7.593M	$7.593M
YoY Change	168.98%	5144.72%	1756.0%
Other Long-Term Liabilities	$6.389M	$71.71K	$71.71K
YoY Change	3877.2%
Total Long-Term Liabilities	$14.02M	$7.665M	$7.665M
YoY Change	367.7%	5194.25%	1773.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.397M	$6.644M	$6.644M
Total Long-Term Liabilities	$14.02M	$7.665M	$7.665M
Total Liabilities	$19.42M	$14.31M	$14.31M
YoY Change	273.48%	732.37%	732.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.10M	-$27.10M
YoY Change	84.02%	80.11%
Common Stock	$678.00	$3.727K
YoY Change	-79.6%	12.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.381M	$2.355M	$2.355M
YoY Change
Total Liabilities & Shareholders Equity	$21.80M	$16.66M	$16.66M
YoY Change	77.41%	56.7%	56.7%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$4.000M	-$3.751M	-$12.00M
YoY Change	114.35%	34.33%	328.57%
Depreciation, Depletion And Amortization	$398.3K	$456.9K	$1.358M
YoY Change	58.73%	23.02%	265.49%
Cash From Operating Activities	-$5.835M	-$3.268M	-$9.200M
YoY Change	140.15%	-31.56%	91.67%
INVESTING ACTIVITIES
Capital Expenditures	$117.8K	-$1.040M	$549.9K
YoY Change	-22.74%	164.43%	39.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$117.8K	$1.040M	-$549.9K
YoY Change	-22.74%	-364.43%	39.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.490M	4.513M	$8.825M
YoY Change	-2575.18%	-55.12%	-12.62%
NET CHANGE
Cash From Operating Activities	-$5.835M	-3.268M	-$9.200M
Cash From Investing Activities	-$117.8K	1.040M	-$549.9K
Cash From Financing Activities	$3.490M	4.513M	$8.825M
Net Change In Cash	-$2.463M	2.286M	-$973.6K
YoY Change	-9.57%	-53.25%	-119.92%
FREE CASH FLOW
Cash From Operating Activities	-$5.835M	-$3.268M	-$9.200M
Capital Expenditures	$117.8K	-$1.040M	$549.9K
Free Cash Flow	-$5.953M	-$2.228M	-$9.750M
YoY Change	130.54%	-49.15%	87.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37267237
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37267237
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33222192
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33222192
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	149900	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	guer	Common Stock Voting Rights Vote Per Share CommonStockVotingRightsVotePerShare	1	pure
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2600000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	300000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56238
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-3837067
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27455
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2000 Pisgah Church Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Greensboro
CY2022	dei	City Area Code CityAreaCode	336
CY2022	dei	Local Phone Number LocalPhoneNumber	510-7840
CY2022	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 par value per share
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	37713020	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40550624
CY2022Q4	us-gaap	Cash Cash	4340407	usd
CY2021Q4	us-gaap	Cash Cash	5313985	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1124971	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1667006	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	643401	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1187418	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7781704	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9607423	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	3574746	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	5098097	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1027312	usd
CY2022Q4	us-gaap	Assets Assets	16664216	usd
CY2021Q4	us-gaap	Assets Assets	10634735	usd
CY2022Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	959803	usd
CY2021Q4	guer	Shortterm Debt And Longterm Debt Current Maturities ShorttermDebtAndLongtermDebtCurrentMaturities	5117	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	118420	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4466045	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1186443	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6644148	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1309980	usd
CY2022Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	44279	usd
CY2021Q4	guer	Longterm Debt Noncurrent Excluding Longterm Notes Payable LongtermDebtNoncurrentExcludingLongtermNotesPayable	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	264347	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4564564	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1719110	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3727	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	3322	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	144783	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14309323	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29424334	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23958705	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27073168	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15046402	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16664216	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10634735	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11600904	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10479899	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4835632	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4340292	usd
CY2022	us-gaap	Gross Profit GrossProfit	6765272	usd
CY2021	us-gaap	Gross Profit GrossProfit	6139607	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8114377	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4592879	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4634012	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2752153	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5138410	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2464295	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17886799	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	9809327	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-11121527	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3669720	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-874713	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-551495	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30526	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1384060	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-905239	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	832565	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2837155	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33302237
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11704201
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3125294	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2837155	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36995	usd
CY2021	guer	Stock Issued During Period Value Change Par Value StockIssuedDuringPeriodValueChangeParValue	-1767	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	270	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8382826	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1477	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	176045	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8915625	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5232	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4765232	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	643570	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2354893	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12026766	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2837155	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1357571	usd
CY2021	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	1369100	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	371435	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14960	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	643570	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	176045	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	48070	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2022	guer	Amortization Of Warrants AmortizationOfWarrants	0	usd
CY2021	guer	Amortization Of Warrants AmortizationOfWarrants	45527	usd
CY2022	guer	Gain Loss On Ppp Loan Forgiveness GainLossOnPPPLoanForgiveness	-0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	12794	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-542035	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13201	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	233911	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	458175	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-862375	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1086971	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	761948	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	354385	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1203295	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9248403	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4819376	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	549850	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	393359	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-549850	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-393359	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	9070726	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	5097870	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	4765232	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5232	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	36995	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	3977778	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	4150701	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	985622	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100839	usd
CY2022	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities	53115	usd
CY2021	guer	Repayment Of Finance Insurance Premiums Financing Activities RepaymentOfFinanceInsurancePremiumsFinancingActivities		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8382826	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	833300	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8824675	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10099451	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-973578	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4886716	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	427269	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4340407	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5313985	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	4745311	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	144177	usd
CY2022	guer	Other Longterm Asset Additions Included In Accounts Payable OtherLongtermAssetAdditionsIncludedInAccountsPayable	2369612	usd
CY2021	guer	Other Longterm Asset Additions Included In Accounts Payable OtherLongtermAssetAdditionsIncludedInAccountsPayable	0	usd
CY2022	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	382843	usd
CY2021	guer	Financing Of Insurance Premium And Software FinancingOfInsurancePremiumAndSoftware	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	327400	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	52000	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5988602	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15873	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	50625	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin: 0pt; font-size: 10pt; font-family: "Times New Roman";"><b><em style="font: inherit;">1.</em> Organization and Nature of Business</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp., the “Company”) was incorporated in the State of Delaware on <em style="font: inherit;"> November 9, 2020. </em>On <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021,</em> the Company's wholly-owned subsidiary, Guerrilla RF Acquisition Corp., a corporation formed in the State of Delaware on <em style="font: inherit;"> October </em><em style="font: inherit;">20,</em> <em style="font: inherit;">2021</em> (“Acquisition Sub”) and privately held Guerrilla RF Operating Corporation (formerly known as Guerrilla RF, Inc.) entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, on <em style="font: inherit;"> October </em><em style="font: inherit;">22,</em> <em style="font: inherit;">2021</em> (the “Closing Date”), Acquisition Sub merged with and into Guerrilla RF Operating Corporation with Guerrilla RF Operating Corporation continuing as the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Prior to the Merger, Laffin Acquisition Corp. was a “shell” company registered under the Exchange Act, with <em style="font: inherit;">no</em> specific business plan or purpose until it began operating the business of Guerrilla RF Operating Corporation following the closing of the Merger.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All references in these Consolidated Financial Statements to “Guerrilla RF” refer to Guerrilla RF Operating Corporation, our direct, wholly-owned subsidiary. Unless otherwise stated or the context otherwise indicates, references to the “Company”, “we”, “our”, “us” or similar terms refer to Guerrilla RF, Inc. (formerly known as Laffin Acquisition Corp.) together with its wholly-owned subsidiary, Guerrilla RF. Guerrilla RF holds all material assets and conducts all business activities and operations of the Company. Accordingly, throughout these Consolidated Financial Statements, there are frequent references to Guerrilla RF. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Guerrilla RF designs and manufactures high‐performance Monolithic Microwave Integrated Circuits (MMICs) for the wireless infrastructure market. Guerrilla RF primarily focuses on researching and developing its existing products and building an infrastructure to handle a global distribution network; therefore, it has incurred significant start‐up losses. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Merger was accounted for as a “reverse acquisition” since, immediately following the consummation of the Merger, Guerrilla RF effectively controlled the Company. For accounting purposes, Guerrilla RF was deemed to be the accounting acquirer in the Merger and, consequently, the Merger is treated as a recapitalization of Guerrilla RF (i.e., a capital transaction involving the issuance of shares by the Company for the shares of Guerrilla RF). Accordingly, the assets, liabilities, and results of operations of Guerrilla RF became the historical consolidated financial statements of the Company, and the Company’s assets, liabilities, and results of operations were consolidated with Guerrilla RF beginning at the Closing Date. <em style="font: inherit;">No</em> step-up in basis or intangible assets or goodwill were recorded in the Merger.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Liquidity and Going Concern</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">Per Accounting Standards Update (“ASU”) <em style="font: inherit;">No.</em> <em style="font: inherit;">2014</em>-<em style="font: inherit;">15</em><i>, Disclosure of Uncertainties about an Entity</i>’<i>s Ability to Continue as a Going Concern (Subtopic <em style="font: inherit;">205</em>-<em style="font: inherit;">40</em>)</i>, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within <em style="font: inherit;">one</em> year after the date that the consolidated financial statements are issued.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">The accompanying consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the ordinary course of business. The Company has historically financed its activities principally from common and preferred equity securities and debt issuance.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">The Company has incurred substantial negative cash flows from operations in nearly every fiscal period since inception. For the year ended <em style="font: inherit;"> December 31, 2022, </em>the Company incurred a net loss of<span style="background-color:#ffffff;"> $12.0 million and used $9.2 million in</span> cash to fund operations. As a result, the Company had an accumulated deficit <span style="background-color:#ffffff;">of $27.1 million</span> as of <em style="font: inherit;"> December 31, 2022. </em>The Company's cash as of <em style="font: inherit;"> December 31, 2022 </em>wa<span style="background-color:#ffffff;">s $4.3 million. </span>We expect losses and negative cash flows to continue in the near term, primarily due to continued investment in research and development, sales and marketing efforts, and increased administration expenses as our Company grows. We plan to continue to invest in the implementation of our long-term strategic plan and we anticipate that we will require additional funding in fiscal <em style="font: inherit;">2023.</em> There is <em style="font: inherit;">no</em> assurance that appropriate funding will be available on terms, which are acceptable to us, or at all. This requirement for additional funding raises substantial doubt about our ability to continue as a going concern.</p> <p style="text-align: justify; font-size: 10pt; font-family: "Times New Roman"; margin: 0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;"> </p> <p style="text-align: justify; font-size: 10pt; font-family: "Times New Roman"; margin: 0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">Our primary source of liquidity is cash raised from private placements and debt financing. We also have <em style="font: inherit;">two</em> loan facilities, <em style="font: inherit;">one</em> of which is for up to $3.0 million with a specialty lender (referred to as the Spectrum Loan Facility, described in Note <em style="font: inherit;">5</em> to our consolidated financial statements), and the other of which is for up to <em style="font: inherit;">$8.0</em> million with a different lender (referred to as the Salem Loan Facility, also described in Note <em style="font: inherit;">5</em> to our consolidated financial statements). As of <em style="font: inherit;"> December 31, 2022, </em>we had drawn down <em style="font: inherit;">$0.72</em> million under the Spectrum Loan Facility and <em style="font: inherit;">$5.0</em> million under the Salem Loan Facility. The Company raised gross proceeds of approximately $9.2 million in a private placement offering with the final closing on <em style="font: inherit;"> February 28, 2023, </em>including $4.2 million after <em style="font: inherit;"> December 31, 2022, </em>to further support its current and future liquidity needs. The Company believes that its existing cash and cash equivalents will provide sufficient resources to support operations through the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023.</em> Potentially, the Company could draw down additional funds under the Spectrum Loan Facility; however, its ability to do so is dependent upon the value of eligible accounts receivable assigned to Spectrum as security for advances under the Spectrum Loan Facility, which value fluctuates from time to time and is ultimately outside of the Company’s control. In addition, the Company anticipates seeking permission from Salem to draw down up to an additional $3.0 million of the $8.0 million Salem Loan Facility; however, Salem has discretion to, and <em style="font: inherit;"> may, </em>decline the Company’s request. The Company is also pursuing additional funding opportunities, including planning for a further capital raise in the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023</em> in connection with its planned uplisting to the Nasdaq or another national securities exchange. In the event the Company is unable to secure these or other funding sources, it <em style="font: inherit;"> may </em>be unable to fund ongoing operations and pay its obligations as they become due after the <em style="font: inherit;">second</em> quarter of <em style="font: inherit;">2023.</em> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -9pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt -1pt; text-align: justify;">The Company will require additional funds to respond to business challenges, including developing new solutions or enhancing existing solutions, enhancing our operating infrastructure, expanding our sales and marketing capabilities, and acquiring complementary businesses, technologies, or assets. We plan to engage in additional equity or debt financing to secure the necessary funds; however, equity and debt financing might <em style="font: inherit;">not</em> be available when needed or, if available, might <em style="font: inherit;">not</em> be available on terms satisfactory to us. If we raise additional funds through equity financing, our stockholders <em style="font: inherit;"> may </em>experience dilution. Debt financing, if available, <em style="font: inherit;"> may </em>involve covenants restricting our operations or our ability to incur additional debt. If we are unable to obtain adequate financing or financing on terms satisfactory to us in the future, our ability to continue as a going concern, to support our business growth, and to respond to business challenges could be significantly limited as we <em style="font: inherit;"> may </em>have to delay, reduce the scope of, or eliminate some or all of our initiatives, which could harm our operating results.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Risks and Uncertainties</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company is subject to several risks associated with companies at a similar stage, including dependence on key individuals, competition from similar products and larger companies, volatility of the industry, ability to obtain adequate financing to support growth, the ability to attract and retain additional qualified personnel to manage the anticipated growth of the Company, and general economic conditions.</p>
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12000000.0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9200000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27100000	usd
CY2022Q4	us-gaap	Cash Cash	4300000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9200000	usd
CY2022	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	250000	usd
CY2021	guer	Contract With Customer Liability Revenue To Be Recognized ContractWithCustomerLiabilityRevenueToBeRecognized	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. In addition, the Company’s significant estimates and judgments involve the identification of performance obligations in revenue recognition and the valuation of share-based compensation, including the<span style="background-color:#ffffff;"> underlying fair value of the common stock. According</span>ly, actual results could differ from those estimates.</p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"/> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentrations of Credit Risk and Major Customers</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Financial instruments at <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em> that potentially subject the Company to concentration of credit risk consist primarily of cash and accounts receivable.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company’s cash is deposited with major financial institutions in the U.S. At times, deposits in financial institutions located in the U.S. <em style="font: inherit;"> may </em>be in excess of the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation (FDIC). To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its cash deposits.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s accounts receivable are derived from revenue earned from customers located in and outside of the U.S. Major customers are defined as those generating revenue in excess of <em style="font: inherit;">10%</em> of the Company’s annual product shipment revenue. The Company h<span style="background-color:#ffffff;">ad <span style="-sec-ix-hidden:c94119710"><span style="-sec-ix-hidden:c94119711">one</span></span> m</span>ajor customer during the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em>. Revenues from the major customer accounted f<span style="background-color:#ffffff;">or 81% o</span>f product shipment revenue for both the years ended <em style="font: inherit;"> December 31, 2022 </em>and <em style="font: inherit;">2021</em>. Accounts receivable from our major customer represented<span style="background-color:#ffffff;"> 76%</span> of accounts receivable at <em style="font: inherit;"> December 31, 2022, </em>a<span style="background-color:#ffffff;">nd 78%</span> of accounts receivable at <em style="font: inherit;"> December 31, 2021</em>.</p>
CY2022Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022	guer	Factoring Agreement Receivables Term Oustanding FactoringAgreementReceivablesTermOustanding	P90D
CY2022Q4	guer	Factoring Agreement Percentage Of Receivables Collateral FactoringAgreementPercentageOfReceivablesCollateral	0.15	pure
CY2022Q2	guer	Proceeds From Accounts Receivable Factoring ProceedsFromAccountsReceivableFactoring	3000000	usd
CY2022Q4	guer	Accounts Receivable Secured Debt Facility Receivables Assigned AccountsReceivableSecuredDebtFacilityReceivablesAssigned	700000	usd
CY2022Q4	guer	Accounts Receivable Secured Debt Facility Amount Due AccountsReceivableSecuredDebtFacilityAmountDue	100000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	5568646	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	39219	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	18108	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	0	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7336239
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3512462
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	696409	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	629090	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	44037	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	339746	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932479	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	482972	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	-0	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12794	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672925	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1439014	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	12794	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2523521
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2523521
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	18861	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7999029	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2605800	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2900932	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1578488	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5098097	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1027312	usd
CY2022	us-gaap	Depreciation Depreciation	1357571	usd
CY2021	us-gaap	Depreciation Depreciation	371435	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20000	usd
CY2022Q4	guer	Factoring Agreement Advance Amount Percentage Of Accounts Receivable FactoringAgreementAdvanceAmountPercentageOfAccountsReceivable	0.85	pure
CY2022Q4	guer	Factoring Agreement Factoring Fee First Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeFirstThirtyDaysPercentageOfInvoiceFaceValue	0.0098	pure
CY2022Q4	guer	Factoring Agreement Factoring Fee After Thirty Days Percentage Of Invoice Face Value FactoringAgreementFactoringFeeAfterThirtyDaysPercentageOfInvoiceFaceValue	0.000327	pure
CY2022Q4	guer	Factoring Agreement Minimum Invoice Fee FactoringAgreementMinimumInvoiceFee	1.50	usd
CY2022	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	0	usd
CY2021	us-gaap	Cash Flows Between Transferee And Transferor Servicing Fees CashFlowsBetweenTransfereeAndTransferorServicingFees	87122	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	5568646	usd
CY2022	guer	Notes Payable Excluding Current Portion NotesPayableExcludingCurrentPortion	-959803	usd
CY2021	guer	Notes Payable Excluding Current Portion NotesPayableExcludingCurrentPortion	5117	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4608843	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	144783	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	959803	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	18360	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6092	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	4565530	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3300000	usd
CY2022Q4	guer	Sharebased Payment Arrangement Granted Award Option Cost Not Yet Recognized Amount SharebasedPaymentArrangementGrantedAwardOptionCostNotYetRecognizedAmount	500000	usd
CY2022	guer	Sharebased Payment Arrangement Granted Award Cost Not Yet Recognized Period For Recognition SharebasedPaymentArrangementGrantedAwardCostNotYetRecognizedPeriodForRecognition	P2Y3M18D
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	568000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1260000
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.70
CY2022	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	1.57
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.52	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.67	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0396	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0011	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.30
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.97
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3209141
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.67
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M24D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	82716
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.97
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	110975
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.36
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3180882
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	472000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.30
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12702
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.41
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	32862
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.95
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3607318
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.59
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2905460
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.37
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M25D
CY2021Q4	guer	Factor Of Change In Exercise Price Of Options FactorOfChangeInExercisePriceOfOptions	2.95	pure
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12702
CY2022Q4	guer	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	461253	usd
CY2021Q4	guer	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	272585	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	39598	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11090	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	112336	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	65127	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	5856	usd
CY2021Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	4860	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	643570000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	176046000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2600000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	300000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	209669	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	139794	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71714	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	211508	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4124093	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1078506	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2984618	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4063124	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	135842	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	131191	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	977771	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	79495	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	251228	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	21108	usd
CY2022	guer	Finance Lease Cost FinanceLeaseCost	1228999	usd
CY2021	guer	Finance Lease Cost FinanceLeaseCost	100603	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3994815	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3452349	usd
CY2022Q4	guer	Deferred Tax Assets Nel Carryforwards DeferredTaxAssetsNelCarryforwards	239315	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M23D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M23D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0735	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0705	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	133637	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	251228	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	985622	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1329924	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1305620	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	984853	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	902927	usd
CY2022Q4	guer	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	116018	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	4639342	usd
CY2022Q4	guer	Finance Lease Liability Undiscounted Excess Amount Next Twelve Months FinanceLeaseLiabilityUndiscountedExcessAmountNextTwelveMonths	251418	usd
CY2022Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Two FinanceLeaseLiabilityUndiscountedExcessAmountYearTwo	176040	usd
CY2022Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Three FinanceLeaseLiabilityUndiscountedExcessAmountYearThree	104265	usd
CY2022Q4	guer	Finance Lease Liability Undiscounted Excess Amount Year Four FinanceLeaseLiabilityUndiscountedExcessAmountYearFour	42185	usd
CY2022Q4	guer	Finance Lease Liability Undiscounted Excess Amount After Year Four FinanceLeaseLiabilityUndiscountedExcessAmountAfterYearFour	2310	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	576218	usd
CY2022Q4	guer	Finance Lease Liability Year One FinanceLeaseLiabilityYearOne	1078506	usd
CY2022Q4	guer	Finance Lease Liability Year Two FinanceLeaseLiabilityYearTwo	1129580	usd
CY2022Q4	guer	Finance Lease Liability Year Three FinanceLeaseLiabilityYearThree	880588	usd
CY2022Q4	guer	Finance Lease Liability Year Four FinanceLeaseLiabilityYearFour	860742	usd
CY2022Q4	guer	Finance Lease Liability After Year Four FinanceLeaseLiabilityAfterYearFour	113708	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	4063124	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	150687	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	73193	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	223880	usd
CY2022Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year One LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearOne	10893	usd
CY2022Q4	guer	Lessee Operating Lease Liability Undiscounted Excess Amount Year Two LesseeOperatingLeaseLiabilityUndiscountedExcessAmountYearTwo	1479	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12372	usd
CY2022Q4	guer	Operating Lease Liability Year One OperatingLeaseLiabilityYearOne	139794	usd
CY2022Q4	guer	Operating Lease Liability Year Two OperatingLeaseLiabilityYearTwo	71714	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	211508	usd
CY2022Q4	guer	Lessee Operating Lease Lease Not Yet Commenced Annual Lease Expense LesseeOperatingLeaseLeaseNotYetCommencedAnnualLeaseExpense	1100000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.022	pure
CY2021Q4	guer	Deferred Tax Assets Nel Carryforwards DeferredTaxAssetsNelCarryforwards	324685	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	626347	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	365668	usd
CY2022Q4	guer	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	48594	usd
CY2021Q4	guer	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	0	usd
CY2022Q4	guer	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	1639623	usd
CY2021Q4	guer	Deferred Tax Assets Capitalized Research And Development Expense DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpense	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7167737	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4496364	usd
CY2022Q4	guer	Deferred Tax Liabilities Trade Receivables And Prepaid Expenses DeferredTaxLiabilitiesTradeReceivablesAndPrepaidExpenses	374517	usd
CY2021Q4	guer	Deferred Tax Liabilities Trade Receivables And Prepaid Expenses DeferredTaxLiabilitiesTradeReceivablesAndPrepaidExpenses	655804	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	48171	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	-0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	422688	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	655804	usd
CY2022Q4	guer	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	6745049	usd
CY2021Q4	guer	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	3840560	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6745049	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3840560	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.020	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.020	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.008	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.010	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance	0.050	pure
CY2022	guer	Effective Income Tax Rate Reconciliation Provision To Return True Up Percent EffectiveIncomeTaxRateReconciliationProvisionToReturnTrueUpPercent	-0.006	pure
CY2021	guer	Effective Income Tax Rate Reconciliation Provision To Return True Up Percent EffectiveIncomeTaxRateReconciliationProvisionToReturnTrueUpPercent	0.010	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.040	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.242	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.300	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.100	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	120000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2588000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	336383	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	208105	usd
CY2022	dei	Auditor Name AuditorName	FORVIS, LLP
CY2022	dei	Auditor Location AuditorLocation	Raleigh, NC
CY2022	dei	Auditor Firm AuditorFirmId	57

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
guer-20221231_def.xml	Edgar Link	unprocessable
0001437749-23-005378-index-headers.html	Edgar Link	pending
0001437749-23-005378-index.html	Edgar Link	pending
0001437749-23-005378.txt	Edgar Link	pending
0001437749-23-005378-xbrl.zip	Edgar Link	pending
a01.jpg	Edgar Link	pending
a02.jpg	Edgar Link	pending
a03.jpg	Edgar Link	pending
ex_447897.htm	Edgar Link	pending
ex_447898.htm	Edgar Link	pending
ex_447899.htm	Edgar Link	pending
ex_447900.htm	Edgar Link	pending
ex_447901.htm	Edgar Link	pending
ex_481871.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
guer-20221231.xsd	Edgar Link	pending
guer20221231_10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
guer-20221231_cal.xml	Edgar Link	unprocessable
guer-20221231_pre.xml	Edgar Link	unprocessable
guer20221231_10k_htm.xml	Edgar Link	completed
guer-20221231_lab.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GUER
Guerrilla RF Inc Stock $guer

2023 Q1 Form 10-K Financial Statement

#000143774923005378 Filed on March 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER Guerrilla RF Inc Stock $guer

2023 Q1 Form 10-K Financial Statement

#000143774923005378 Filed on March 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GUER
Guerrilla RF Inc Stock $guer